China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024 Read more
Vgenomics, Dr. Shroff Charity Eye Hospital partner to validate biomarker for early Keratoconus detection Read more
Zydus Lifesciences’ provides an update on its campaign from promoting breast cancer awareness Read more
Lupin announces presentation of phase 1 data on LNP7457 (PRMT5 inhibitor) at the ASCO – Annual Meeting 2025 Read more
Lupin and SteinCares enter into License and Supply Agreement for Ranibizumab in Latin America Read more